Russ Altman, Stanford University
Kim Branson, GSK
In conversation with: Jack Fuchs
Principled Engineering: AI and Drug Development [Entire Talk]
AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.